Utah has passed sweeping changes to a new voter-approved medical-marijuana ballot measure under a planned compromise that secured support of the influential Mormon church but sparked a backlash from advocates.
Supporters of the compromise cheered the vote, saying it would help suffering patients while creating safeguards against broader recreational use.
“I believe this agreement was a landmark day for our state, and we are helping people,” said outgoing Republican House speaker Greg Hughes, who sponsored the legislation and helped bring together the players for talks.
The plan for changes was announced before Election Day as part of a broad compromise that won the backing of The Church of Jesus Christ of Latter-day Saints.
The changes ban many marijuana edibles, prevent people from growing their own marijuana if they live far from a dispensary and narrow the list of eligible medical conditions for which the drug can be obtained.
Smoking marijuana was not allowed in the original ballot measure and won’t be under the new version.
Democrats argued the measure’s passage with 53 per cent of the vote shows people want it as written, and they proposed leaving the original language intact. Republicans overwhelmingly voted down the idea. [Read more at The Independent]
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Notify me of follow-up comments by email.
Notify me of new posts by email.
POSaBIT, the cannabis point-of-sale (POS) and payments software company, this morning announced its planned acquisition of MJ Platform (MJ Freeway), Leaf Data Systems, and Ample Organics from embattled software company…
New York marijuana regulators on Wednesday approved dozens of conditional adult-use dispensary licenses in a session during which members also discussed adopting bylaws for how the board runs meetings and makes decisions.…
By Griffin Thorne, Attorney at Harris Bricken Since the passage of the 2018 Farm Bill, the hemp CBD industry has been eagerly awaiting FDA CBD regulations. In that time, FDA…
The US Food and Drug Administration has finalized a 2020 draft guidance outlining how sponsors and investigators can conduct clinical trials for certain drugs containing cannabis or cannabis-derived compounds without…